17 results
8-K
EX-99.1
BCLI
Brainstorm Cell Therapeutics, Inc.
20 Jun 23
BrainStorm Cell Therapeutics Appoints Nir Naor as Board Member and Audit Committee Chair
5:01pm
outcomes, the impacts of the COVID-19 pandemic on our clinical trials, supply chain, and operations, and other factors detailed in BrainStorm's
8-K
EX-99.1
BCLI
Brainstorm Cell Therapeutics, Inc.
6 Jun 23
Regulation FD Disclosure
8:58am
, the impacts of the COVID-19 pandemic on our clinical trials, supply chain, and operations, and other factors detailed in BrainStorm's annual report on Form
8-K
EX-99.1
BCLI
Brainstorm Cell Therapeutics, Inc.
15 May 23
BrainStorm Cell Therapeutics Announces First Quarter 2023 Financial Results and Provides Corporate Update
7:15am
clinical trials, supply chain, and operations, and other factors detailed in BrainStorm's annual report on Form 10-K and quarterly reports on Form 10-Q
8-K
EX-99.1
n4hk5a3ljg00rr49ufa
30 Mar 23
BrainStorm Cell Therapeutics Announces Full Year 2022 Financial Results and Provides a Corporate Update
7:18am
8-K
EX-99.1
g31h0q yt
14 Nov 22
BrainStorm Cell Therapeutics Announces Third Quarter 2022 Financial Results and Provides a Corporate Update
7:15am
8-K
EX-99.1
vgdlp
11 Oct 22
BrainStorm Presents New Biomarker Analyses from NurOwn’s Phase 3 ALS Trial at the ALS ONE Research Symposium
8:01pm
8-K
rhvkt 376z
11 Oct 22
BrainStorm Presents New Biomarker Analyses from NurOwn’s Phase 3 ALS Trial at the ALS ONE Research Symposium
8:01pm
8-K
EX-99.1
6a1384xtjjssqqlo9fd
15 Aug 22
BrainStorm Cell Therapeutics Announces Second Quarter 2022 Financial Results and Provides a Corporate Update
7:22am
8-K
EX-99.1
fr84a dtass2q0z
16 May 22
BrainStorm Cell Therapeutics Announces First Quarter 2022 Financial Results and Provides a Corporate Update
7:16am
8-K
EX-99.1
hg2kka55 ty3if2oyed
28 Mar 22
BrainStorm Cell Therapeutics Announces Full Year 2021 Financial
7:15am
8-K
EX-99.1
20x7waj
4 Feb 21
BrainStorm Announces Full Year 2020 Financial Results and Provides a Corporate Update
7:05am
- Prev
- 1
- Next